|
|
Blood, 1 July 2006, Vol. 108, No. 1, pp. 134-140.
Prepublished online as a Blood First Edition Paper on March 7, 2006; DOI 10.1182/blood-2005-03-1219.
Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment
Siham Sabri,
Adlen Foudi,
Siham Boukour,
Brigitte Franc,
Sabine Charrier,
Martine Jandrot-Perrus,
Richard W. Farndale,
Abdelali Jalil,
Mike P. Blundell,
Elisabeth M. Cramer,
Fawzia Louache,
Najet Debili,
Adrian J. Thrasher, and
William Vainchenker
From the Institut National de la Santé et de la Recherche Médicale (INSERM) U790, Université Paris XI, Institut Gustave Roussy, Villejuif, France; INSERM U567, Département d'Hématologie, Institut Cochin, Maternité Port Royal, Paris, France; Département de Pathology, A. Paré Hospital, Assistance Publique-Hôpitaux de Paris [APHP]), Boulogne, Université de Versailles, Saint Quentin en Yvelines, France; INSERM E348, Faculté Xavier Bichat, Paris, France; the Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom; Institut Fédératif de Recherche (IFR) 54, Université Paris XI, Institut Gustave Roussy, Villejuif, France; and the Molecular Immunology Unit, Institute of Child Health, University College London, London, United Kingdom.
The pathophysiology of microthrombocytopenia in the Wiskott-Aldrich syndrome (WAS) and its milder form, X-linked thrombocytopenia (XLT), is unclear. Although quantitative defects are correctable by splenectomy, residual platelet abnormalities are suggestive of intrinsic disturbances of production. In contrast to human patients, murine models of WASp deficiency exhibit only mild thrombocytopenia, and platelets are of normal size. Here, we have identified a critical role for WASp during murine platelet biogenesis. By electron microscopy, WASp-deficient MKs appeared to have shed platelets ectopically within the bone marrow space. WASp-deficient megakaryocytes (MKs) also displayed defects in response to fibrillar collagen I (CI) in vitro, the major matrix component of bone. These included a loss of normal CI receptor ( 2 1 integrin)-mediated inhibition of proplatelet formation, a marked abrogation of SDF-1-induced chemotactic migration of CD41+ MKs adherent to CI, and an almost complete lack of actin-rich podosomes, normally induced by interaction between CI and its receptors GPVI or 2 1 integrin. These findings highlight the central and highly specialized role of WASp in MKs during platelet biogenesis, and may provide a mechanism for the mild thrombocytopenia observed in WASp-deficient mice. In addition, they suggest a novel explanation for some of the platelet abnormalities characteristic of patients with WAS. (Blood. 2006;108:134-140)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Falet, M. P. Marchetti, K. M. Hoffmeister, M. J. Massaad, R. S. Geha, and J. H. Hartwig
Platelet-associated IgAs and impaired GPVI responses in platelets lacking WIP
Blood,
November 19, 2009;
114(21):
4729 - 4737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zou, A. A. Schmaier, L. Cheng, P. Mericko, S. K. Dickeson, T. P. Stricker, S. A. Santoro, and M. L. Kahn
Negative regulation of activated {alpha}2 integrins during thrombopoiesis
Blood,
June 18, 2009;
113(25):
6428 - 6439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bosticardo, F. Marangoni, A. Aiuti, A. Villa, and M. Grazia Roncarolo
Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome
Blood,
June 18, 2009;
113(25):
6288 - 6295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Geddis
The regulation of proplatelet production
Haematologica,
June 1, 2009;
94(6):
756 - 759.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Eckly, C. Strassel, M. Freund, J.-P. Cazenave, F. Lanza, C. Gachet, and C. Leon
Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation
Blood,
April 2, 2009;
113(14):
3182 - 3189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.-c. Cheng, Q. Luo, E. M. Bruscia, M. J. Renda, J. A. Troy, S. A. Massaro, D. Tuck, V. Schulz, S. M. Mane, N. Berliner, et al.
Role for MKL1 in megakaryocytic maturation
Blood,
March 19, 2009;
113(12):
2826 - 2834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Eto, H. Nishikii, T. Ogaeri, S. Suetsugu, A. Kamiya, T. Kobayashi, D. Yamazaki, A. Oda, T. Takenawa, and H. Nakauchi
The WAVE2/Abi1 complex differentially regulates megakaryocyte development and spreading: implications for platelet biogenesis and spreading machinery
Blood,
November 15, 2007;
110(10):
3637 - 3647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T. Nurden and P. Nurden
Inherited thrombocytopenias
Haematologica,
September 1, 2007;
92(9):
1158 - 1164.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Chen, O. Naveiras, A. Balduini, A. Mammoto, M. A. Conti, R. S. Adelstein, D. Ingber, G. Q. Daley, and R. A. Shivdasani
The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway
Blood,
July 1, 2007;
110(1):
171 - 179.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|